| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Hopital Laval Research Center, Laval University, Quebec City, Canada
2 Hopital Laval Research Center, Laval University, Quebec City, Canada; Laval University, United States
* To whom correspondence should be addressed. E-mail: marie.arsenault{at}crhl.ulaval.ca.
Objectives: To assess the long term effects of beta blockade on survival and LV remodeling in rats with aortic valve regurgitation (AR).
Background: The pharmacological management of chronic AR remains controversial. Until now, no drug has been definitively proven effective to delay the need for valve replacement or to affect morbidity and/or mortality. Our group has reported that the adrenergic system is activated in an animal model of AR and that adrenergic blockade may help maintain a normal left ventricular (LV) function. The effects of a prolonged treatment with a beta-blocker are unknown.
Methods: 40 Wistar rats with severe AR were divided in 2 groups (n=20/gr) treated or not with metoprolol (MET) 25 mg/kg/day for 1 year. LV remodeling was evaluated by echocardiography. Survival was assessed by Kaplan-Meir curves. Hearts were harvested for tissue analysis.
Results: All animals treated with MET were alive after 6 months compared with 70% of untreated animals. After 1 year, 60% of MET animals were alive vs. 35% untreated (p=0.028). All but 1 death were sudden. There were no differences in LVEF (all above 50%) or LV dimensions. LV mass tended to be lower in the MET group. There was less sub-endocardial fibrosis in this group as well as lower LV filling pressures (LVEDP). Beta adrenergic receptor ratio (
1/2) was improved.
Conclusion: A 1-year treatment with metoprolol was well tolerated. Metoprolol improved 1 year survival, minimized left ventricular hypertrophy, improved LV filling pressures, decreased LV sub-endocardial fibrosis and helped restore beta adrenergic receptor ratio.
This article has been cited by other articles:
|
|
 |
|
  D. Lachance, E. Plante, A.-A. Bouchard-Thomassin, S. Champetier, E. Roussel, M.-C. Drolet, M. Arsenault, and J. Couet Moderate Exercise Training Improves Survival and Ventricular Remodeling in an Animal Model of Left Ventricular Volume Overload Circ Heart Fail, September 1, 2009; 2(5): 437 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sampat, P. Varadarajan, R. Turk, A. Kamath, S. Khandhar, and R. G. Pai Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 452 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Elkayam Beta-blockers in the treatment of aortic regurgitation a new opportunity? J. Am. Coll. Cardiol., July 28, 2009; 54(5): 458 - 459. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hess Jr, P. K. Harman, C. T. Klodell, T. M. Beaver, M. T. Bologna, P. Mikhail, C. G. Tribble, and T. D. Martin Early Outcomes Using the Florida Sleeve Repair for Correction of Aortic Insufficiency due to Root Aneurysms Ann. Thorac. Surg., April 1, 2009; 87(4): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Champetier, A. Bojmehrani, J. Beaudoin, D. Lachance, E. Plante, E. Roussel, J. Couet, and M. Arsenault Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the {beta}-adrenergic and renin-angiotensin systems Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H669 - H677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Plante, D. Lachance, J. Beaudoin, S. Champetier, E. Roussel, M. Arsenault, and J. Couet Comparative Study of Vasodilators in an Animal Model of Chronic Volume Overload Caused by Severe Aortic Regurgitation Circ Heart Fail, January 1, 2009; 2(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
